EGCG may reduce the hyperphosphorylation of the tau protein and downregulate BACE1 and Aβ1-42 expression, enhancing the antioxidant system and cognitive functions in rats with AD [110]. The gene discussed is MAPT; the disease is Alzheimer disease.